{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:35:51Z","timestamp":1791272151204,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC101-2320-B-010-072-MY3"],"award-info":[{"award-number":["NSC101-2320-B-010-072-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC101-2321-B-010-027"],"award-info":[{"award-number":["NSC101-2321-B-010-027"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC101-2325-B-001-038"],"award-info":[{"award-number":["NSC101-2325-B-001-038"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC98-2314-B-182A-027-MY3"],"award-info":[{"award-number":["NSC98-2314-B-182A-027-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC98-2320-B-010-002-MY3"],"award-info":[{"award-number":["NSC98-2320-B-010-002-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-99-TP-B12"],"award-info":[{"award-number":["AS-99-TP-B12"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005382","name":"National Yang-Ming University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jaci.2013.04.036","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T02:15:17Z","timestamp":1371608117000},"page":"713-722.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["A new nucleic acid\u2013based agent inhibits cytotoxic T\u00a0lymphocyte\u2013mediated immune disorders"],"prefix":"10.1016","volume":"132","author":[{"given":"Chuang-Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nien-Wen","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konan","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Tsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Iu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.04.036_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"issue":"196","key":"10.1016\/j.jaci.2013.04.036_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-00663-0_2","article-title":"Drug hypersensitivity reactions involving skin","author":"Hausmann","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jaci.2013.04.036_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.04.036_bib4","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.04.036_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2013.04.036_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2007.06.017","article-title":"HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome","volume":"120","author":"Yang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib8","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.04.036_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1399-0039.2008.01218.x","article-title":"Biology and clinical relevance of granulysin","volume":"73","author":"Krensky","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaci.2013.04.036_bib11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/aps.2009.132","article-title":"A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia","volume":"30","author":"Li","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jaci.2013.04.036_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib13","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2013.04.036_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.beha.2008.07.003","article-title":"Advances in the clinical management of GVHD (TNF & GVHD)","volume":"21","author":"Ferrara","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jaci.2013.04.036_bib15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nri2200","article-title":"Specificity of T-cell alloreactivity","volume":"7","author":"Felix","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0198-8859(00)00228-7","article-title":"Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation","volume":"62","author":"Sarwal","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.20570","article-title":"Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction","volume":"81","author":"Nagasawa","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2013.04.036_bib18","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.ajpath.2011.06.040","article-title":"Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection","volume":"179","author":"Ashokkumar","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2013.04.036_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.04.036_bib20","first-page":"29","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options","volume":"50","author":"Teo","year":"2009","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jaci.2013.04.036_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1365-4632.2007.03277.x","article-title":"Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"46","author":"Fromowitz","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2013.04.036_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaci.2013.04.036_bib23","first-page":"CD005565","article-title":"Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation","author":"Salmasian","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2013.04.036_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1991.18","article-title":"OKT3 first-dose reaction: association with T cell subsets and cytokine release","volume":"39","author":"Gaston","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaci.2013.04.036_bib25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.04.036_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","article-title":"The promises and pitfalls of RNA-interference-based therapeutics","volume":"457","author":"Castanotto","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.04.036_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2013.04.036_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bioeng.2007.06.001","article-title":"SELEX\u2014a (r)evolutionary method to generate high-affinity nucleic acid ligands","volume":"24","author":"Stoltenburg","year":"2007","journal-title":"Biomol Eng"},{"key":"10.1016\/j.jaci.2013.04.036_bib29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0167-5699(00)01750-3","article-title":"Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor","volume":"21","author":"Gao","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaci.2013.04.036_bib30","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1096\/fj.09-129312","article-title":"Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses","volume":"23","author":"Chang","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2013.04.036_bib31","doi-asserted-by":"crossref","first-page":"11422","DOI":"10.1128\/JVI.79.17.11422-11433.2005","article-title":"Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta","volume":"79","author":"Stove","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2013.04.036_bib32","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.4049\/jimmunol.169.10.5787","article-title":"CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15","volume":"169","author":"Ma","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/nbt1161","article-title":"Activation of the mammalian immune system by siRNAs","volume":"23","author":"Marques","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2013.04.036_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkp829","article-title":"Sequence-non-specific effects of RNA\u00a0interference triggers and microRNA regulators","volume":"38","author":"Olejniczak","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2013.04.036_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-6143.2008.02533.x","article-title":"Ex\u00a0vivo inhibition of NF-kappaB signaling in alloreactive T-cells prevents graft-versus-host disease","volume":"9","author":"O'Shaughnessy","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaci.2013.04.036_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2005-05-1820","article-title":"NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145","volume":"107","author":"Vodanovic-Jankovic","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.04.036_bib37","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.4049\/jimmunol.175.11.7244","volume":"175","author":"Contini","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib38","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.4049\/jimmunol.176.7.4173","article-title":"A novel NF-kappaB binding site controls human granzyme B gene transcription","volume":"176","author":"Huang","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2567.2002.01524.x","article-title":"Opposing roles of activator protein-1 and CCAAT\/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1","volume":"107","author":"Kida","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2013.04.036_bib40","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1111\/j.1742-4658.2010.07904.x","article-title":"Efficient and targeted delivery of siRNA in\u00a0vivo","volume":"277","author":"Shim","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.jaci.2013.04.036_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2013.04.036_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1758-907X-1-4","article-title":"Aptamer-targeted cell-specific RNA interference","volume":"1","author":"Zhou","year":"2010","journal-title":"Silence"},{"key":"10.1016\/j.jaci.2013.04.036_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/oli.2010.0264","article-title":"Cell-specific aptamer-mediated targeted drug delivery","volume":"21","author":"Zhou","year":"2011","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.jaci.2013.04.036_bib44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","article-title":"Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras","volume":"24","author":"McNamara","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2013.04.036_bib45","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/nar\/gkp185","article-title":"Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells","volume":"37","author":"Zhou","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2013.04.036_bib46","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1172\/JCI45876","article-title":"Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras","volume":"121","author":"Wheeler","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2013.04.036_bibE1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2007.06.017","article-title":"HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome","volume":"120","author":"Yang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bibE2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.04.036_bibE3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/1074-7613(94)90075-2","article-title":"The CD8 coreceptor revisited: one chain good, two chains better","volume":"1","author":"Zamoyska","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.04.036_bibE4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0167-5699(00)01750-3","article-title":"Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor","volume":"21","author":"Gao","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaci.2013.04.036_bibE5","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/nar\/gkq996","article-title":"A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia","volume":"39","author":"Mallikaratchy","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2013.04.036_bibE6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/ac701962v","article-title":"Identification of liver cancer-specific aptamers using whole live cells","volume":"80","author":"Shangguan","year":"2008","journal-title":"Anal Chem"},{"key":"10.1016\/j.jaci.2013.04.036_bibE7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1074-7613(00)80351-9","article-title":"CD8 lineage commitment in the absence of CD8","volume":"6","author":"Goldrath","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.04.036_bibE8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1128\/JVI.78.4.1685-1696.2004","article-title":"Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity","volume":"78","author":"Alexander","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2013.04.036_bibE9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2013.04.036_bibE10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jim.2011.06.026","article-title":"Transfection optimization for primary human CD8+ cells","volume":"372","author":"Liu","year":"2011","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2013.04.036_bibE11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/CDLI.8.6.1131-1135.2001","article-title":"Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants","volume":"8","author":"Neri","year":"2001","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913006830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913006830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:40:03Z","timestamp":1758789603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913006830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0091674913006830"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.04.036","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new nucleic acid\u2013based agent inhibits cytotoxic T\u00a0lymphocyte\u2013mediated immune disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}